Substituted dimeric compounds
US6319930A · kind A · utility
3Cited by
0References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 24, 2000 |
| Grant date | Nov 20, 2001 |
| Priority date | — |
| Expiry date | Mar 24, 2020 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2602/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to compounds of formula (I): EQU A--G.sub.1 --Cy--G.sub.2 --Cy--G.sub.3 --B (I) wherein: PA1 A represents NR.sup.1 C(Q)R.sup.2, C(Q)NR.sup.2 R.sup.3 or NR.sup.1 C(Q)NR.sup.2 R.sup.3, PA1 B represents NR.sup.1 C(Q)R.sup.2, C(Q)NR.sup.2 R.sup.3, NR.sup.1 C(Q)NR.sup.2 R.sup.3, C(Q)OR.sup.1, NR.sup.1 C(Q)OR.sup.2 or NR.sup.2 R.sup.3, PA1 G.sub.1 and G.sub.3 represent an optionally substituted alkylene chain, PA1 Cy represents a ring structure ##STR1## and PA1 G2 represents a chain ##STR2## and medicinal products containing the same which are useful in treating or in preventing melatoninergic disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.